• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

作者信息

Nathan David M, Buse John B, Davidson Mayer B, Ferrannini Ele, Holman Rury R, Sherwin Robert, Zinman Bernard

机构信息

Diabetes Center, Massachusetts General Hospital, Boston, MA 02114, USA.

出版信息

Diabetes Care. 2008 Jan;31(1):173-5. doi: 10.2337/dc08-9016.

DOI:10.2337/dc08-9016
PMID:18165348
Abstract
摘要

相似文献

1
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.2型糖尿病高血糖管理：治疗起始与调整的共识算法：噻唑烷二酮类药物的更新：美国糖尿病协会和欧洲糖尿病研究协会的共识声明
Diabetes Care. 2008 Jan;31(1):173-5. doi: 10.2337/dc08-9016.
2
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.2型糖尿病高血糖管理：治疗起始与调整的共识算法：美国糖尿病协会和欧洲糖尿病研究协会的共识声明
Diabetes Care. 2007 Jan;30(1):193; author reply 194-6. doi: 10.2337/dc06-1828.
3
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.2型糖尿病高血糖管理：治疗起始与调整的共识算法：美国糖尿病协会和欧洲糖尿病研究协会的共识声明
Diabetes Care. 2007 Jan;30(1):193-4. doi: 10.2337/dc06-2060.
4
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.2型糖尿病高血糖管理：治疗起始与调整的共识算法：美国糖尿病协会和欧洲糖尿病研究协会的共识声明
Diabetes Care. 2007 Jan;30(1):192-3; author reply 194-6. doi: 10.2337/dc06-1858.
5
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.2型糖尿病高血糖管理：治疗起始与调整的共识算法：美国糖尿病协会和欧洲糖尿病研究协会的共识声明
Diabetes Care. 2007 Jan;30(1):190-2; author reply 194-6. doi: 10.2337/dc-06-1670.
6
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.2型糖尿病高血糖管理：治疗起始与调整的共识算法：美国糖尿病协会和欧洲糖尿病研究协会的共识声明：对纳坦等人的回应
Diabetes Care. 2007 Apr;30(4):e16-7; author reply e18-20, e21-2. doi: 10.2337/dc06-2373.
7
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.2型糖尿病高血糖的医学管理：治疗起始与调整的共识算法：美国糖尿病协会和欧洲糖尿病研究协会的共识声明：对纳坦等人的回应
Diabetes Care. 2009 Mar;32(3):e35-6; author reply e37-8. doi: 10.2337/dc08-2275.
8
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.2型糖尿病高血糖的医学管理：治疗起始与调整的共识算法：美国糖尿病协会和欧洲糖尿病研究协会的共识声明：对纳坦等人的回应
Diabetes Care. 2009 Mar;32(3):e34; author reply e37-8. doi: 10.2337/dc08-2093.
9
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Response to Nathan et al.2型糖尿病高血糖的医学管理：治疗起始与调整的共识算法：美国糖尿病协会和欧洲糖尿病研究协会的共识声明。对纳森等人的回应
Diabetes Care. 2009 May;32(5):e58; author rely e59. doi: 10.2337/dc09-0125.
10
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.2型糖尿病高血糖管理：治疗起始与调整的共识算法。美国糖尿病协会和欧洲糖尿病研究协会的共识声明。
Diabetologia. 2006 Aug;49(8):1711-21. doi: 10.1007/s00125-006-0316-2.

引用本文的文献

1
Updating and calibrating the Real-World Progression In Diabetes (RAPIDS) model in a non-Veterans Affairs population.在非退伍军人事务人群中更新和校准真实世界糖尿病进展（RAPIDS）模型。
Diabetes Obes Metab. 2024 Nov;26(11):5261-5271. doi: 10.1111/dom.15878. Epub 2024 Sep 2.
2
Exploring Rosiglitazone's Potential to Treat Alzheimer's Disease through the Modulation of Brain-Derived Neurotrophic Factor.探索罗格列酮通过调节脑源性神经营养因子治疗阿尔茨海默病的潜力。
Biology (Basel). 2023 Jul 24;12(7):1042. doi: 10.3390/biology12071042.
3
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus.
新型非胰岛素抗糖尿病药物成本效益研究的系统评价：用于模拟 2 型糖尿病的决策分析模型的趋势。
Pharmacoeconomics. 2023 Nov;41(11):1469-1514. doi: 10.1007/s40273-023-01268-5. Epub 2023 Jul 6.
4
Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment.二肽基肽酶4抑制剂在抗糖尿病治疗新时代中的作用。
World J Diabetes. 2022 Feb 15;13(2):85-96. doi: 10.4239/wjd.v13.i2.85.
5
Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.二甲双胍与2型糖尿病患者患恶性脑肿瘤的风险
Biomolecules. 2021 Aug 17;11(8):1226. doi: 10.3390/biom11081226.
6
Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies.富含欧米伽-3 脂肪酸的鱼油补充剂可预防罗格列酮引起的老龄 C57BL/6 小鼠骨质疏松症和体外研究。
Sci Rep. 2021 May 14;11(1):10364. doi: 10.1038/s41598-021-89827-8.
7
Dexmedetomidine exerts neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b.右美托咪定通过抑制 miR-125b 在高糖诱导的神经损伤中发挥神经保护作用。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200394.
8
Prospect of Sodium-Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes.钠-葡萄糖协同转运蛋白 2 抑制剂联合胰岛素治疗 2 型糖尿病的前景。
Front Endocrinol (Lausanne). 2020 Apr 15;11:190. doi: 10.3389/fendo.2020.00190. eCollection 2020.
9
Improved insulin injection technique, treatment satisfaction and glycemic control: Results from a large cohort education study.改进胰岛素注射技术、治疗满意度和血糖控制：一项大型队列教育研究的结果
J Clin Transl Endocrinol. 2020 Feb 4;19:100217. doi: 10.1016/j.jcte.2020.100217. eCollection 2020 Mar.
10
Thiazolidinediones: the Forgotten Diabetes Medications.噻唑烷二酮类药物：被遗忘的糖尿病药物。
Curr Diab Rep. 2019 Nov 27;19(12):151. doi: 10.1007/s11892-019-1270-y.